Loading market dashboard
Knight Therapeutics Inc.
GUD.TOHealthcareTSXCA
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Knight Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $599.65M | $584.84M - $613.59M | $81.53M | $0.35 | 1 |
| Dec 2029 | $577.69M | $563.42M - $591.12M | $78.54M | $0.31 | 2 |
| Dec 2028 | $547.75M | $547.75M - $547.75M | $74.47M | $0.29 | 3 |
| Dec 2027 | $527.66M | $508.13M - $546.96M | $71.74M | $0.21 | 6 |
| Dec 2026 | $520.44M | $514.08M - $525.51M | $70.76M | $0.184 | 7 |
| Dec 2025 | $435.53M | $433.18M - $440.98M | $59.21M | -$0.124 | 6 |
| Dec 2024 | $361.56M | $357.18M - $364.98M | $49.16M | -$0.051 | 7 |
| Dec 2023 | $337.87M | $329.53M - $345.73M | $45.94M | -$0.206 | 6 |
| Dec 2022 | $274.63M | $271.33M - $278.06M | $49.30M | -$0.19 | 2 |
| Dec 2021 | $247.00M | $244.02M - $250.08M | $44.34M | $0.20 | 3 |
| Dec 2020 | $192.49M | $190.17M - $194.89M | $34.56M | $0.237 | 5 |
| Dec 2019 | $41.93M | $41.42M - $42.45M | $7.53M | $0.179 | 2 |